Fingerprint
Dive into the research topics of 'MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus
Peter M.K. De Blank, Andrea M. Gross, Srivandana Akshintala, Jaishri O. Blakeley, Gideon Bollag, Ashley Cannon, Eva Dombi, Jason Fangusaro, Bruce D. Gelb, Darren Hargrave, Ae Rang Kim, Laura J. Klesse, Mignon Loh, Staci Martin, Christopher Moertel, Roger Packer, Jonathan M. Payne, Katherine A. Rauen, Jonathan J. Rios, Nathan Robison
Research output: Contribution to journal › Review article › peer-review
29
Scopus
citations